Floatz logo

Monomethyl Fumarate

Congenital Amegakaryocytic Thrombocytopenia

Roswell Park Cancer InstituteSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Congenital Amegakaryocytic Thrombocytopenia cohort.

Asset / SponsorPhaseRating
Fludarabine
Fred Hutchinson Cancer Center
Phase 2BB
Busulphan
University of California, San Francisco
Phase 2BB
METHOTREXATE
Fred Hutchinson Cancer Center
Phase 2BB
Thiotepa
Fred Hutchinson Cancer Center
Phase 2BB
Romidepsin
University of California, San Francisco
Phase 2BB

View all 16 →

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →